Literature DB >> 2612050

Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis.

C M Holt1, N Lindsey, J Moult, R G Malia, M Greaves, A Hume, N R Rowell, P Hughes.   

Abstract

Ten sera from 48 patients with systemic sclerosis were found to be capable of producing cytotoxicity of human umbilical venous and arterial endothelium when co-cultured with peripheral blood mononuclear cells. Fractionation of sera on Ultrogel and the preparation of monomeric IgG by ion exchange and affinity chromatography suggested that the cytotoxicity was mediated by anti-endothelial antibodies capable of pre-sensitizing target cells in a mechanism that resembled antibody-dependent cellular cytotoxicity. These anti-endothelial antibodies together with C1q-binding immune complexes and anti-cardiolipin antibodies were found in 18 of 28 patients so investigated, suggesting that multiple immunological mechanisms may be involved in the pathogenesis of the vascular lesion of systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612050      PMCID: PMC1534812     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome.

Authors:  D L TUFFANELLI
Journal:  Am J Med Sci       Date:  1962-02       Impact factor: 2.378

2.  A class of specific cytotoxic cells demonstrated in vitro by arming with antigen-antibody complexes.

Authors:  A H Greenberg; L Shen
Journal:  Nat New Biol       Date:  1973-10-31

3.  Factor VIII related antigen: an improved enzyme immunoassay.

Authors:  P E Short; C E Williams; A M Picken; F G Hill
Journal:  Med Lab Sci       Date:  1982-10

4.  Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.

Authors:  R M Bernstein; J C Steigerwald; E M Tan
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

5.  Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.

Authors:  H R Maricq; E C LeRoy; W A D'Angelo; T A Medsger; G P Rodnan; G C Sharp; J F Wolfe
Journal:  Arthritis Rheum       Date:  1980-02

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Serum-induced enhancement of peripheral blood mononuclear cell-mediated cytotoxicity towards human target cells in systemic sclerosis.

Authors:  C A Penning; J K Wright; J C Ashby; J Cunningham; N R Rowell; P Hughes
Journal:  J Clin Lab Immunol       Date:  1983-10

8.  Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.

Authors:  P Hughes; J Cunningham; M Day; J C Fitzgerald; M A French; J K Wright; N R Rowell
Journal:  J Clin Lab Immunol       Date:  1983-03

9.  Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.

Authors:  J van der Maulen; A A Wouda; E Mandema; T H The
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

Review 10.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

View more
  19 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Rare spontaneously transformed human endothelial cell line provides useful research tool.

Authors:  K Takahasi; Y Sawasaki
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

3.  Expression of HLA-DR antigen on hepatic vascular endothelial cells in idiopathic portal hypertension.

Authors:  T Terada; Y Nakanuma; M Hoso; H Obata
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

Authors:  R Sgonc; M S Gruschwitz; H Dietrich; H Recheis; M E Gershwin; G Wick
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.

Authors:  M Hebbar; P Lassalle; Y Delneste; P Y Hatron; B Devulder; A B Tonnel; A Janin
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

6.  Scleroderma and motor neuron disease: an unusual association.

Authors:  R Priori; A Buonopane; A Francia; G Valesini
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

Review 7.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

8.  A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies.

Authors:  D W Koenig; L Barley-Maloney; T O Daniel
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

9.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

Authors:  W J Mayet; A Schwarting; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.